首页> 美国卫生研究院文献>Postgraduate Medical Journal >Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.
【2h】

Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.

机译:小剂量长春新碱在非脾切除患者中治疗皮质类固醇难治性特发性血小板减少性紫癜(ITP)。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Eight non-splenectomized patients with corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) were treated with low-dose vincristine (1 mg/week up to a total dose of 4 mg). Complete remission was achieved in 2 cases and partial remission in 3. Bleeding stopped in one patient who failed to remit. No statistical relationship was found between the response to vincristine and the duration of the disease or the corticosteroid-therapy. Side effects were only observed in one patient. By comparing these results with those reported in the literature, it can be inferred that low-dose vincristine may be useful in the management of corticosteroid-refractory ITP.
机译:用低剂量长春新碱(1 mg /周,总剂量为4 mg)治疗8例非脾切除的皮质类固醇难治性特发性血小板减少性紫癜(ITP)患者。 2例完全缓解,3例部分缓解。1例未能缓解的患者停止了出血。在对长春新碱的反应与疾病持续时间或皮质类固醇治疗之间未发现统计学关系。仅在一名患者中观察到了副作用。通过将这些结果与文献报道的结果进行比较,可以推断出小剂量长春新碱可用于治疗皮质类固醇难治性ITP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号